The ads are aimed at the 40% of Americans who haven’t yet made up their minds about getting vaccinated against COVID-19.
Author: Elizabeth Weise, USA TODAY
‘Somewhere in there, the vaccine got overpromised’: How the COVID-19 vaccination process turned chaotic and confusing
A lack of transparency, coupled with a short supply, has complicated America’s COVID-19 vaccination efforts. Are things getting better now?
Biden hopes Defense Production Act can aid vaccine production. Experts say it will take time.
Biden is invoking the Defense Production Act to speed up COVID-19 vaccines. But can that actually rapidly increase output?
Federal education campaign to emphasize power of COVID-19 vaccine set to launch in January
A long-delayed federal education campaign aimed at encouraging Americans to take the COVID-19 vaccine is set to launch in January.
States were left scrambling after finding out they’d get 20-40% less vaccine than they expected. Here’s why.
After some confusion, the source of the problem was clarified Friday night: States were given estimates based on vaccine doses produced, not those that had been OK’d.
Role-playing, planning for earthquakes, mass training: US health care centers prep for arrival of COVID-19 vaccine
The first doses of Pfizer’s FDA-authorized COVID-19 vaccine will be injected into the arms of health care workers in all 50 states beginning Monday.
Trading COVID-19 vaccines. Regular deliveries. Tracking doses. What we know about Operation Warp Speed distribution process.
Operation Warp Speed, the White House COVID-19 initiative, plans to only ship half of all vaccine available each week.
Getting a vaccine has been a huge undertaking. How all 50 states scramble to dole them out is the next massive challenge.
A USA TODAY survey finds most states are ready to distribute a coronavirus vaccine to health care workers but maybe not all who are next in line.
CDC-convened panel votes to add nursing home residents to first phase of COVID-19 vaccine rollout
Front-line health care workers are clearly first in line for a COVID-19 vaccine. Then there’s the question of who else should be in the initial group.
When might a COVID-19 vaccine be authorized? FDA Commissioner Stephen Hahn answers common questions
Food and Drug Administration Commissioner Stephen Hahn discussed the vaccine approval process and how the FDA will evaluate immunization safety.